Cite
Validation of the Bolondi stratification for intermediate stage hepatocellular carcinoma (HCC). Clinical and therapeutical implications
MLA
Andrea Mega, et al. “Validation of the Bolondi Stratification for Intermediate Stage Hepatocellular Carcinoma (HCC). Clinical and Therapeutical Implications.” Digestive and Liver Disease, vol. 49, Feb. 2017, p. e25. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........3b45bb3529e5b01257aec55412b81aee&authtype=sso&custid=ns315887.
APA
Andrea Mega, M. Haefner, Heinz Zoller, Stefano Fagiuoli, M. De Giorgio, A. Finkenstedt, & M. Felder. (2017). Validation of the Bolondi stratification for intermediate stage hepatocellular carcinoma (HCC). Clinical and therapeutical implications. Digestive and Liver Disease, 49, e25.
Chicago
Andrea Mega, M. Haefner, Heinz Zoller, Stefano Fagiuoli, M. De Giorgio, A. Finkenstedt, and M. Felder. 2017. “Validation of the Bolondi Stratification for Intermediate Stage Hepatocellular Carcinoma (HCC). Clinical and Therapeutical Implications.” Digestive and Liver Disease 49 (February): e25. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........3b45bb3529e5b01257aec55412b81aee&authtype=sso&custid=ns315887.